PAGLIARANI, BARBARA
 Distribuzione geografica
Continente #
EU - Europa 225
AS - Asia 61
NA - Nord America 44
SA - Sud America 12
AF - Africa 8
Totale 350
Nazione #
IT - Italia 165
US - Stati Uniti d'America 39
SG - Singapore 32
CN - Cina 16
DE - Germania 14
BR - Brasile 12
IN - India 10
GB - Regno Unito 7
CI - Costa d'Avorio 6
FR - Francia 5
RU - Federazione Russa 5
AT - Austria 4
ES - Italia 4
FI - Finlandia 4
NL - Olanda 4
CA - Canada 3
IE - Irlanda 3
SE - Svezia 3
BE - Belgio 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
MX - Messico 2
TR - Turchia 2
BG - Bulgaria 1
ID - Indonesia 1
Totale 350
Città #
Bologna 51
Singapore 24
Milan 23
Portogruaro 17
Santa Clara 9
Abidjan 6
Forlì 6
Rimini 6
San Giorgio di Piano 6
Boardman 5
Cesena 5
Delhi 4
Hyderabad 4
Boscoreale 3
Dublin 3
Falconara Marittima 3
Rome 3
Seriate 3
Stockholm 3
São Paulo 3
Ashburn 2
Beijing 2
Birkerød 2
Bonn 2
Bremen 2
Cairo 2
Calderara di Reno 2
Campobasso 2
Civitanova Marche 2
Dresden 2
Fethiye 2
Helsinki 2
Jena 2
Kerken 2
Lucknow 2
Naples 2
New York 2
Porto Alegre 2
Ravenna 2
Santarcangelo di Romagna 2
Shenzhen 2
Tlalpan 2
Toronto 2
Trento 2
Trieste 2
Valencia 2
Warminster 2
Amsterdam 1
Arta 1
Barcelona 1
Blumenau 1
Boydton 1
Brussels 1
Carpaneto Piacentino 1
Crevalcore 1
Fiume Veneto 1
Florence 1
Fort Worth 1
Frankfurt am Main 1
Giromagny 1
Jakarta 1
Kilburn 1
Lappeenranta 1
London 1
Los Angeles 1
Middlesbrough 1
New Bedfont 1
Ottawa 1
Parma 1
Prineville 1
Pátrai 1
Qingdao 1
Reston 1
Rocca Pia 1
Senigallia 1
Shijiazhuang 1
Sofia 1
Southwark 1
Taiyuan 1
Teià 1
The Bronx 1
Utrecht 1
Totale 276
Nome #
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 200
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 60
Chrysin bonded to β-d-glucose tetraacetate enhances its protective effects against the neurotoxicity induced by aluminum in Swiss mice 55
Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson’s disease 38
Antioxidant and Neuroprotective Effects of Fucoxanthin and Its Metabolite Fucoxanthinol: A Comparative In Vitro Study 20
Totale 373
Categoria #
all - tutte 1.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024146 7 6 21 11 18 13 10 7 7 10 19 17
2024/2025227 21 28 25 28 56 14 21 25 9 0 0 0
Totale 373